CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ½ÅÁ¤¿ø
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ³úÀüÁõ(°æ·Ã¼ºÁúȯ)/½Ç½Å/¼ö¸éÀå¾Ö/ÀÎÁöÀúÇÏ/³ú¿°
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
110 (±¹³»)KCI Ç÷°ü³»ÇǼºÀåÀÎÀÚÀ¯ÀüÀÚ ´ÜÀÏ´ºÅ¬·¹¿ÀƼµå´ÙÇüÅÂ¿Í ´ë³ú¹éÁúº¯¼º À§Ç輺ÀÇ ¿¬°ü¼ººÐ¼®
109 (±¹¿Ü)SCIE Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial.
108 (±¹³»)±âŸ In vivo Tracking of Human Neural Stem Cells Following Transplantation into a Rodent Model of Ischemic Stroke
107 (±¹¿Ü)SCI Bladder and bowel dysfunction following small-volume epidural blood patch for spontaneous intracranial hypotension.
106 (±¹¿Ü)SCIE diffuse cortical hypometabolism on 18F-FDG-PET scan in a case of an adult variant cerebello-brainstem dominant form of ALD manifesting dementia
105 (±¹¿Ü)±âŸ Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.
104 (±¹¿Ü)SCI The hsa-miR-5787 represses cellular growth by targeting eukaryotic translation initiation factor 5 (eIF5) in fibroblasts
103 (±¹³»)SCIE Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
102 (±¹¿Ü)SCI Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease
101 (±¹³»)KCI ¸¸¼ºCÇü°£¿° ȯÀÚ¿¡¼­ ¾ËÆÄ-ÀÎÅÍÆä·Ð Ä¡·á ÈÄ ¹ß»ýÇÑ ¸¸¼º¿°ÁõÅ»¼öÃʴٹ߽Ű溴 1¿¹
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729